TY - JOUR T1 - The cost-effectiveness of schistosomiasis screening and treatment among recently resettled refugees to Canada: an economic evaluation JF - CMAJ Open JO - CMAJ SP - E125 LP - E133 DO - 10.9778/cmajo.20190057 VL - 9 IS - 1 AU - John A. Webb AU - Gabriel Fabreau AU - Eldon Spackman AU - Stephen Vaughan AU - Kerry McBrien Y1 - 2021/01/01 UR - http://www.cmajopen.ca/content/9/1/E125.abstract N2 - Background: Many refugees and asylum seekers from countries where schistosomiasis is endemic are infected with the Schistosoma parasite when they arrive in Canada. We assessed, from a systemic perspective, which of the following management strategies by health care providers is cost-effective: testing for schistosomiasis and treating if the individual is infected, treating presumptively or waiting for symptoms to emerge.Methods: We constructed a decision-tree model to examine the cost-effectiveness of 3 management strategies: watchful waiting, screening and treatment, and presumptive treatment. We obtained data for the model from the literature and other sources, to predict deaths and chronic complications caused by schistosomiasis, as well as costs and net monetary benefit.Results: Presumptive treatment was cost-saving if the prevalence of schistosomiasis in the target population was greater than 2.1%. In our baseline analysis, presumptive treatment was associated with an increase of 0.156 quality-adjusted life years and a cost saving of $405 per person, compared with watchful waiting. It was also more effective and less costly than screening and treatment.Interpretation: Among recently resettled refugees and asylum claimants in Canada, from countries where schistosomiasis is endemic, presumptive treatment was predicted to be less costly and more effective than watchful waiting or screening and treatment. Our results support a revision of the current Canadian recommendations. ER -